BTIG Downgrades Foghorn Therapeutics (FHTX) to Neutral
BTIG analyst Jeet Mukherjee downgraded Foghorn Therapeutics (NASDAQ: FHTX) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

